Du är här


Hofseth Biocare ASA : Share capital increase registered in HBC

Reference is made to the stock exchange notice published on 11 April 2014
regarding the completion of a private placement of NOK 90 million and the
stock exchange notice published on 2 May 2014 regarding the extraordinary
general meeting's approval of the private placement.

The share capital increase related to the private placement has now been
registered with the Norwegian Register of Business Enterprises.

The new share capital of Hofseth BioCare is NOK 97,536,088 divided into
97,536,088 shares, each with a nominal value of NOK 1.

The new shares will not be tradable on Oslo Axess before a prospectus relevant
thereto has been approved by the Norwegian Financial Supervisory Authority.

For further information, please contact:
Jon Olav Ødegård, CEO Hofseth BioCare ASA
Tel +47 936 32 966
E-mail: joo@h-bc.no

Øystein Omvik, CFO Hofseth BioCare ASA
Tel: +47 936 99 400
E-mail: oystein.omvik@h-bc.no

About Hofseth BioCare:
Hofseth BioCare is a Norwegian biomarine company with the key objective to
provide high value added biomarine ingredients for human applications. The
Company is founded on the core value of sustainability and optimal use of
natural resources. Through innovative production technology and logistics,
Hofseth BioCare is able to preserve the quality of protein, calcium and oil
extracted from fish off-cuts. Products that previously could only be used as
animal feed can now be made suitable for human consumption. HBC's objective
is thus to contribute to efficient use of marine resources and entering the
higher profit market of quality ingredients for human applications.

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hofseth Biocare ASA via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.